Protein profiling plays an essential part in today’s biomedical research, striving to improve patients’ quality of life by using molecular signatures for diagnosis and treatment guidance.

At Sciomics, we believe that our explorative proteomic and post-translational modification profiling platform enables true progress in precision medicine.

Therefore, our internal development pipeline of innovative biomarker signatures for precision medicine is based on this powerful platform. We have currently a focused project on prediction of a severe COVID-19 disease course as well as a project on prediction and early diagnosis of peri-operative Acute Kidney Injury (AKI).

In addition, we offer services based on our scioDiscover profiling platform and R&D collaborations for

• discovery and validation of novel biomarkers
• drug target screening
• characterization of disease models
• the analysis of pathway activity
• mode-of-action analyses